Worked for Novo Nordisk for 9 years initially as Filling Process supporter and Local PAS-X super user and designer. From 2021 as Advanced MES analyst in DD&IT PS MES CoE in Novo Nordisk. Currently part of the central PAS-X NextGen Migration Excellence team with focus on migration of all NN sites from CORE 2 to CORE 3.

We are a global healthcare company, founded in 1923 and headquartered just outside Copenhagen, Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases such as obesity, and rare blood and rare endocrine diseases. We do so by pioneering scientific breakthroughs, expanding access to our medicines and working to prevent and ultimately cure the diseases we treat. We employ more than 55,000 people in 80 offices around the world, and market our products in 170 countries.